in

COVID-19: FDA approves , first herbal medicine , Nibima , for clinical trial

Nibima , FDA approves first herbal medicine for clinical trial
FDA approves first herbal medicine for clinical trial

FDA approves first herbal medicine, Nibima, for clinical trial

The Food and Drugs Authority (FDA) has approved Ghana’s first herbal medicine for clinical trial on COVID-19 treatment.

This follows results from laboratory studies conducted by the Kwame Nkrumah University of Science and Technology (KNUST) research team.

This means the medicine, Cryptolepis Sanguinolenta, locally known as Nibima stands a better chance of being used to treat COVID-19 if it is approved after the trial.

A statement signed and released by FDA CEO Delese Darko said the authority remains committed to protect the health and safety of consumers.

GhLinks Media

Written by GhLinks Media

This is the official publishing account of https://www.ghlinks.com.gh/ for all general based post .

Demand COVID-19 Tests From Men Before Accepting Proposals – Ursula Owusu

Demand COVID-19 Tests , From Men Before Accepting Proposals – Ursula Owusu

Akufo Addo’s Ban On Funerals Effectively Prevents Anlo Chiefs From Holding Another Funeral For Rawlings

Akufo Addo’s Ban On Funerals Effectively Prevents Anlo Chiefs From Holding Another Funeral For Rawlings